2Tambe K, Bhargava J, Tripathi A, Gregory M, Burns J,Sampath R. The role of intravenous methylprednisolone immunosuppression in the management of active thyroid eye disease[J].Orbits, 2010,29(05): 227-231.
2Limaiem R, Limaiem F, Kourda N, et al. Primary orbital hemangiopericytoma: an unusual cause of unilateral proptosis. Can J Neurol Sci, 2010, 37 : 279-282.
3Krasny J, Sach J, Brunnerova R, et al. Orbital tumors in adults: a 10-year study. Cesk Slov Oftalmol (Czech), 2008, 64: 219-227.
4Lemke AJ, Kazi I, Felix R. Magnetic resonance imaging of orbital tumors. Eur Radiol, 2006, 16: 2207-2219.
5Roshdy N, Shahin M, Kishk H, et al. Role of new magnetic resonance imaging modalities in diagnosis of orbital masses: a clinicopathologic correlation. Middle East Afr J Ophthalmol, 2010, 17: 175-179.
6Xian JF, Zhang Z, Wang ZC, et al. Value of MR imaging in the differentiation of benign and malignant orbital tumors in adults. Eur Radiol, 2010, 20: 1692-1702.
7Kim UR, Khazaei H, Stewart WB, et al. Spectrum of orbital disease in south india: an aravind study of 6328 consecutive patients. Ophthal Plast Reconstr Surg, 2010, 26: 315-322.
8Xian JF, Zhang Z, Wang ZC, et al. Evaluation of MR imaging findings differentiating cavernous haemangiomas from schwannomas in the orbit. Eur Radiol, 2010, 20 : 2221-2228.
9Shenk Y, Jarosz B, Zarnowski T. Primmy manifestations of lymphomas in the orbit. Klin Oczna (Polish), 2009, 111: 235 -239.
10Lena G, Pech-Gourg G, Scavarda D, et al. Optic nerve glioma in children. Neuroehirurgie (French), 2010, 56: 249-256.
